155
Participants
Start Date
October 9, 2017
Primary Completion Date
November 1, 2018
Study Completion Date
December 3, 2018
RESIPI Management Strategy
a structured hemodynamic monitoring and treatment plan: RESIPI includes normalization of vascular resistance, correction of fluid responsiveness, and inotropy, and hemodynamic monitoring with the Starling SV (Cheetah Medical, Inc).
No intervention
No intervention
Vanderbilt University Medical Center, Nashville
Collaborators (1)
Cheetah Medical Inc.
INDUSTRY
Vanderbilt University Medical Center
OTHER